21757762|t|Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons.
21757762|a|Emerging evidence indicates that amyloid beta peptide (Abeta) initially induces subtle alterations in synaptic function in Alzheimer disease. We have recently shown that Abeta binds to beta(2) adrenergic receptor (beta(2)AR) and activates protein kinase A (PKA) signaling for glutamatergic regulation of synaptic activities. Here we show that in the cerebrums of mice expressing human familial mutant presenilin 1 and amyloid precursor protein genes, the levels of beta(2)AR are drastically reduced. Moreover, Abeta induces internalization of transfected human beta(2)AR in fibroblasts and endogenous beta(2)AR in primary prefrontal cortical neurons. In fibroblasts, Abeta treatment also induces transportation of beta(2)AR into lysosome, and prolonged Abeta treatment causes beta(2)AR degradation. The Abeta-induced beta(2)AR internalization requires the N terminus of the receptor containing the peptide binding sites and phosphorylation of beta(2)AR by G protein-coupled receptor kinase, not by PKA. However, the G protein-coupled receptor kinase phosphorylation of beta(2)AR and the receptor internalization are much slower than that induced by betaAR agonist isoproterenol. The Abeta-induced beta(2)AR internalization is also dependent on adaptor protein arrestin 3 and GTPase dynamin, but not arrestin 2. Functionally, pretreatment of primary prefrontal cortical neurons with Abeta induces desensitization of beta(2)AR, which leads to attenuated response to subsequent stimulation with isoproterenol, including decreased cAMP levels, PKA activities, PKA phosphorylation of serine 845 on alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor subunit 1 (GluR1), and AMPA receptor-mediated miniature excitatory postsynaptic currents. This study indicates that Abeta induces beta(2)AR internalization and degradation leading to impairment of adrenergic and glutamatergic activities.
21757762	0	27	Amyloid beta peptide-(1-42)	Chemical	-
21757762	185	190	Abeta	Gene	351
21757762	253	270	Alzheimer disease	Disease	MESH:D000544
21757762	300	305	Abeta	Gene	351
21757762	315	342	beta(2) adrenergic receptor	Gene	154
21757762	344	353	beta(2)AR	Gene	154
21757762	493	497	mice	Species	10090
21757762	509	514	human	Species	9606
21757762	531	543	presenilin 1	Gene	5663
21757762	548	573	amyloid precursor protein	Gene	351
21757762	595	604	beta(2)AR	Gene	154
21757762	640	645	Abeta	Gene	351
21757762	685	690	human	Species	9606
21757762	691	700	beta(2)AR	Gene	154
21757762	731	740	beta(2)AR	Gene	154
21757762	797	802	Abeta	Gene	351
21757762	844	853	beta(2)AR	Gene	154
21757762	883	888	Abeta	Gene	11820
21757762	906	915	beta(2)AR	Gene	154
21757762	933	938	Abeta	Gene	351
21757762	947	956	beta(2)AR	Gene	154
21757762	1073	1082	beta(2)AR	Gene	154
21757762	1199	1208	beta(2)AR	Gene	154
21757762	1279	1285	betaAR	Gene	154
21757762	1294	1307	isoproterenol	Chemical	MESH:D007545
21757762	1313	1318	Abeta	Gene	351
21757762	1327	1336	beta(2)AR	Gene	154
21757762	1429	1439	arrestin 2	Gene	408
21757762	1512	1517	Abeta	Gene	351
21757762	1545	1554	beta(2)AR	Gene	154
21757762	1622	1635	isoproterenol	Chemical	MESH:D007545
21757762	1657	1661	cAMP	Chemical	-
21757762	1815	1820	GluR1	Gene	14799
21757762	1920	1925	Abeta	Gene	351
21757762	1934	1943	beta(2)AR	Gene	154
21757762	Association	154	351
21757762	Negative_Correlation	11820	154
21757762	Association	MESH:D000544	351
21757762	Negative_Correlation	154	5663
21757762	Positive_Correlation	MESH:D007545	154

